D-0327-2021 Class II Terminated

Recalled by Cosette Pharmaceuticals, Inc. — South Plainfield, NJ

FDA drug recall D-0327-2021 was initiated by Cosette Pharmaceuticals, Inc. on Mar 25, 2021 and is designated Class II. Reason for recall: CGMP Deviaitons The recall status is terminated (terminated Jul 17, 2023). Affected quantity: a) 30 mL: 7724 b) 60 mL: 8064 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 14, 2021
Initiation Date
Mar 25, 2021
Termination Date
Jul 17, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 30 mL: 7724 b) 60 mL: 8064 bottles

Product description

Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDC 0713-0701-53), Rx Only, Distributed by: Cosette Pharmaceuticals, Inc., South Plainfield, NJ 07080

Reason for recall

CGMP Deviaitons

Distribution pattern

Nationwide in the US

Code information

a) 30 mL: 1014611 and 1014612, exp 12/2022 b) 60 mL:1014593, 1014594 and 1014595, exp 10/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0327-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0327-2021. Report a data issue: hello@regdatalab.com.